Genetic Toxicology Testing Market Report 2026

Genetic Toxicology Testing Market Overview

• Genetic Toxicology Testing market size has reached to $1.8 billion in 2025 • Expected to grow to $2.74 billion in 2030 at a compound annual growth rate (CAGR) of 8.4% • Growth Driver: Driving Factors For Growth Of Genetic Toxicology Testing Market In The Era Of Personalized Medicine • Market Trend: Toxys Launches MutaTracker®: Advancing Genetic Toxicology Testing with High-Throughput Transcriptomics • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Genetic Toxicology Testing Market?

Genetic toxicology testing is a branch of toxicology that focuses on assessing the potential of chemical substances to cause damage to genetic material, such as DNA, RNA, or chromosomes. The purpose of genetic toxicology testing is to evaluate the genotoxicity of compounds and identify any adverse effects they may have on the genetic material of living organisms, including humans. It is also a critical tool for evaluating the safety of pharmaceuticals, chemicals, and environmental pollutants from genotoxic hazards. The main types of genetic toxicology testing market are in vitro, and in vivo. In vitro refers to experiments or studies that are conducted in a controlled laboratory environment, such as in a test tube, petri dish, or other artificial setting, outside of a living organism. The various products include services, reagents and consumables and assays, which are used in various applications such as the healthcare industry, food industry, cosmetics industry, agriculture industry, and others.

What Is The Genetic Toxicology Testing Market Growth Forecast?

The genetic toxicology testing market size is expected to see strong growth in the next few years. It will grow to $2.74 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to shift toward alternative testing methods, stricter regulatory frameworks, growth in biologics development, demand for safer chemicals, expansion of toxicogenomics. Major trends in the forecast period include increased use of genotoxicity testing in drug development, growing adoption of in vitro genetic toxicology assays, rising regulatory focus on chemical safety testing, expansion of environmental genotoxicity assessment, increased demand from pharmaceutical safety studies.

Global Genetic Toxicology Testing Market Segmentation

1) By Testing Method: In Vitro, In Vivo 2) By Product: Services, Reagents And Consumables, Assays 3) By Application: Healthcare Industry, Food Industry, Cosmetics Industry, Agriculture Industry, Other Applications Subsegments: 1) By In Vitro: Ames Test, Micronucleus Assay, Comet Assay, Chromosomal Aberration Test, Cell Transformation Assay 2) By In Vivo: Micronucleus Test (Rodent), Comet Assay (In Vivo), Bone Marrow Chromosomal Aberration Test, Dominant Lethal Test (Rodent)

What Is The Driver Of The Genetic Toxicology Testing Market?

The increasing demand for personalized medicine is expected to propel the growth of the genetic toxicology testing market going forward. Personalized medicine is a medical model that tailors healthcare decisions, practices, interventions, and products to the individual patient based on their predicted response or disease risk. The personalized medicine market has experienced a positive wave due to genetic breakthroughs, increased understanding of diseases, the availability of biomarker-based diagnostics, value-based healthcare initiatives, and integration into clinical practice and research. Genetic toxicology testing contributes to personalized medicine by providing essential information about genetic variability, susceptibility to genotoxic agents, and treatment response. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized medicines for rare disease patients, a rise from six in 2022. Therefore, the increasing demand for personalized medicine drives the genetic toxicology testing industry.

Key Players In The Global Genetic Toxicology Testing Market

Major companies operating in the genetic toxicology testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings, Eurofins Scientific SE, SGS SA, WuXi AppTec, Intertek Group plc, Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Fraunhofer ITEM, Jubilant Life Sciences Limited, Evotec SE, Inotiv Inc., Promega Corporation, Syngene International Limited, Nelson Laboratories LLC, Instem, Frontage Laboratories Inc., Creative Bioarray, Creative Biolabs Inc., Gentronix Limited, MB Research Laboratories

Global Genetic Toxicology Testing Market Trends and Insights

Major companies operating in the genetic toxicology testing market are focused on developing innovative drug screening platforms, such as high throughput transcriptomics, to improve accuracy and efficiency in identifying potential genetic toxins. High throughput transcriptomics refers to a technology-driven approach that allows large-scale measurement of gene expression (the transcriptome) across many samples in parallel, typically using methods like RNA sequencing (RNA-seq). This enables researchers to assess, in a high-throughput manner, how compounds (e.g., drugs or chemicals) perturb global cellular gene expression, helping predict toxicological effects, modes of action (MOA), and potential genotoxicity. For instance, in September 2024, Toxys, a Netherlands based biotech company specializing in in vitro toxicology solutions, launched MutaTracker, a mammalian cell based mutagenicity and genotoxicity assay that integrates its established ToxTracker reporter system with error corrected single molecule mutation sequencing (SMM seq). This platform enables ultra-sensitive detection of point mutations (as rare as 1 in 10⁷ bases) and provides detailed insight into the genotoxic mode of action, improving accuracy and reducing false positives compared to traditional cytogenetic assays.

What Are Latest Mergers And Acquisitions In The Genetic Toxicology Testing Market?

In September 2024, Scantox Group., a Denmark-based contract research organization, acquired Gentronix for an undisclosed amount. With this acquisition, Scantox aims to expand its portfolio by incorporating Gentronix's expertise in providing genetic toxicology testing. Genitrix Ltd. is a UK-based company that offers accurate genetic toxicology testing.

Regional Outlook

North America was the largest region in the genetic toxicology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Genetic Toxicology Testing Market?

The genetic toxicology testing market includes revenues earned by entities through mutagenicity testing, genotoxicity screening, carcinogenicity testing, regulatory compliance, risk assessment, bacterial mutation assays, comet assays, micronucleus tests, presymptomatic testing, ancestry testing, and nutrigenomics testing, and related cell culture systems, assay kits, microscopes, flow cytometers, automation and robotics, and flow cytometry. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Genetic Toxicology Testing Market Report 2026?

The genetic toxicology testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the genetic toxicology testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.